side effects of noom glp-1 Companion Long-Term Effects Of GLP-1 Medications:
Description
Meanwhile, GLP-1RAs showed a trend towards a reduced risk for nine respiratory diseases, although not reaching statistical significance, including pneumonia (RR 0.89, 95% CI 0.781.00, p = 0.05
however, it suggested the presence of the renoprotective effects of canagliflozin in patients with T2DM and CKD
in 2017 found no evidence that treatment with GLP-1 RAs increases the risk of AP in patients with type 2 diabetes [4]
Some users report receiving medication within 2-3 days
doi: 10.1073/pnas.2014879117 [DOI] [PMC free article] [PubMed] [Google Scholar] 98.Frias JP, Hsia S, Eyde S, et al
In addition, ~30% of patients with epilepsy fail to respond to AEDs, and long-term use affects cognitive function and causes psychological impairments (8,11)
